Wednesday, February 5, 2020

New therapy option identified for early-stage breast cancer

Radionuclide therapy has been successful in delaying the growth of disseminated tumor cells in early-stage breast cancer. Radium-233 dichloride not only impacts cells directly hit by radiation but also has significant effects on cells outside of the radiation field, according to new research.

from Health & Medicine News -- ScienceDaily https://www.sciencedaily.com/releases/2020/02/200205132352.htm

No comments:

Post a Comment